Publication|Articles|April 18, 2025
- Pharmaceutical Executive: April 2025
- Volume 45
- Issue 3
Pharmaceutical Executive: April 2025 Interactive Digital Edition
View the Pharmaceutical Executive April 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
over 1 year ago
‘Earning’ Powerover 1 year ago
Milan Kalawadia: Carving Out New Pathwaysover 1 year ago
Bringing Biotech Innovation Across Bordersover 1 year ago
Using AI to Predict Launch Successover 1 year ago
Improving Your Earned Media Strategy: Tips and Insightsover 1 year ago
The Future of DTC in Pharmaover 1 year ago
Translating ‘Digital-First’ to Commercial Successover 1 year ago
HEOR: From Proving Product Value to Proving Its Own WorthAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
5